Clinical Trial: A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants

U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07271693) titled 'A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants' on Nov. 26.

Brief Summary: The main purpose of this study is to evaluate the safety and tolerability of single and multiple ascending doses of RO7806881 in healthy participants.

Study Start Date: Jan. 16, 2026

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: RO7806881

RO7806881 will be administered as per the schedule specified in the protocol.

DRUG: Placebo

Placebo will be administered as per the schedule specified in the protocol.

Recruitment Status: NOT_YET_RECRUITING

S...